Danish industry seeks to bolster "cautious optimism"
This article was originally published in Clinica
Danish medtech industry association Medicoindustrien says there is cautious optimism for 2009 among the top executives of its member companies. But the creation of working groups in the areas of economics and export suggests it is leaving little to chance.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.